• Cardiovascular Center of The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, P.R.China;
LI Qingguo, Email: lqg0235062@163.com
Export PDF Favorites Scan Get Citation

As an extracorporeal life support technology, veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been demonstrated its role in the treatment of patients with severe respiratory failure. Its main advantages include the ability to maintain adequate oxygenation and remove excess CO2, increase oxygen delivery, improve tissue perfusion and metabolism, and implement lung protection strategies. Clinicians should accurately assess and identify the patient's condition, timely and accurately carry out VV-ECMO operation and management. This article will review the patient selection, cannulation strategy, anticoagulation, clinical management and weaning involved in the application of VV-ECMO.

Citation: LU Fengxia, YAO Hao, REN Yun, LI Qingguo. Research progress of veno-venous extracorporeal membrane oxygenation (VV-ECMO) in the treatment of adult severe respiratory failure. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(12): 1485-1490. doi: 10.7507/1007-4848.202002085 Copy

  • Previous Article

    2020 年欧洲血管外科学会(ESVS)血管移植物感染诊治临床实践指南解读
  • Next Article

    2020 年欧洲血管外科学会(ESVS)血管移植物感染诊治临床实践指南解读